Jon Stobo

405 total citations
9 papers, 153 citations indexed

About

Jon Stobo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jon Stobo has authored 9 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Jon Stobo's work include PARP inhibition in cancer therapy (4 papers), Management of metastatic bone disease (3 papers) and Pleural and Pulmonary Diseases (3 papers). Jon Stobo is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), Management of metastatic bone disease (3 papers) and Pleural and Pulmonary Diseases (3 papers). Jon Stobo collaborates with scholars based in United Kingdom and Norway. Jon Stobo's co-authors include Anthony J. Chalmers, Caroline Kelly, Barry Laird, Nicholas MacLeod, Anna Morris, Karen Moore, Lynn McMahon, N. O’Rourke, Marie Fallon and Jonathan Sheridan and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Neuro-Oncology.

In The Last Decade

Jon Stobo

9 papers receiving 152 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Stobo United Kingdom 5 72 56 38 31 28 9 153
Lokesh Viswanath India 7 48 0.7× 59 1.1× 20 0.5× 28 0.9× 9 0.3× 14 115
Si-Yang Wang China 5 42 0.6× 65 1.2× 19 0.5× 52 1.7× 22 0.8× 6 139
Yun Fan China 8 50 0.7× 73 1.3× 43 1.1× 55 1.8× 8 0.3× 12 146
Ziad Thotathil New Zealand 7 26 0.4× 33 0.6× 24 0.6× 29 0.9× 29 1.0× 13 112
Christine Waibel Switzerland 7 77 1.1× 55 1.0× 37 1.0× 7 0.2× 16 0.6× 12 118
Mikako Ishijima Japan 7 107 1.5× 122 2.2× 18 0.5× 27 0.9× 9 0.3× 15 176
Kaylee M. Keller Netherlands 8 62 0.9× 34 0.6× 43 1.1× 65 2.1× 15 0.5× 10 190
Laura Ginocchi Italy 8 67 0.9× 119 2.1× 47 1.2× 44 1.4× 5 0.2× 17 183
Eduardo Barrascout France 4 122 1.7× 91 1.6× 61 1.6× 27 0.9× 5 0.2× 7 156
Jeannette Dinin United States 2 26 0.4× 93 1.7× 34 0.9× 13 0.4× 8 0.3× 2 128

Countries citing papers authored by Jon Stobo

Since Specialization
Citations

This map shows the geographic impact of Jon Stobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Stobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Stobo more than expected).

Fields of papers citing papers by Jon Stobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Stobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Stobo. The network helps show where Jon Stobo may publish in the future.

Co-authorship network of co-authors of Jon Stobo

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Stobo. A scholar is included among the top collaborators of Jon Stobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Stobo. Jon Stobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Derby, Sarah, Jon Stobo, Allan James, et al.. (2023). OS09.3.A FINAL RESULTS OF THE MGMT UNMETHYLATED ARM OF PARADIGM-2: A PHASE I STUDY OF OLAPARIB AND RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM). Neuro-Oncology. 25(Supplement_2). ii20–ii21. 1 indexed citations
2.
Chalmers, Anthony J., Rodrigo Gutierrez‐Quintana, Karin Williams, et al.. (2021). Abstract IA-006: Enhancing the therapeutic ratio for glioblastoma by combining radiation therapy with PARP inhibitors. Clinical Cancer Research. 27(8_Supplement). IA–6. 1 indexed citations
3.
4.
Ashton, Miranda, N. O’Rourke, Nicholas MacLeod, et al.. (2017). SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma. Clinical and Translational Radiation Oncology. 8. 45–49. 13 indexed citations
5.
Short, Susan, Allan James, Catherine McBain, et al.. (2017). PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status. Clinical and Translational Radiation Oncology. 8. 12–16. 48 indexed citations
6.
Jones, Robert J., Syed A. Hussain, Andrew Protheroe, et al.. (2017). Randomized Phase II Study Investigating Pazopanib Versus Weekly Paclitaxel in Relapsed or Progressive Urothelial Cancer. Journal of Clinical Oncology. 35(16). 1770–1777. 21 indexed citations
7.
8.
MacLeod, Nicholas, Caroline Kelly, Jon Stobo, et al.. (2016). Pain in Malignant Pleural Mesothelioma: A Prospective Characterization Study. Pain Medicine. 17(11). 2119–2126. 12 indexed citations
9.
MacLeod, Nicholas, Anthony J. Chalmers, N. O’Rourke, et al.. (2015). Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial. Journal of Thoracic Oncology. 10(6). 944–950. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lokesh Viswanath Breakdown of academic impact, for papers by Si-Yang Wang Breakdown of academic impact, for papers by Yun Fan Breakdown of academic impact, for papers by Ziad Thotathil Breakdown of academic impact, for papers by Christine Waibel Breakdown of academic impact, for papers by Mikako Ishijima Breakdown of academic impact, for papers by Kaylee M. Keller Breakdown of academic impact, for papers by Laura Ginocchi Breakdown of academic impact, for papers by Eduardo Barrascout Breakdown of academic impact, for papers by Jeannette Dinin
Rankless by CCL
2026